Adherium Limited (ADR.AX)
AUD 0.01
(14.29%)
AUD 0.01
(14.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.4 Million AUD | -1.74% |
| 2023 | 3.46 Million AUD | 15.72% |
| 2022 | 2.99 Million AUD | -0.27% |
| 2021 | 3 Million AUD | -9.9% |
| 2020 | 3.33 Million AUD | 135.79% |
| 2019 | 1.41 Million AUD | -43.69% |
| 2018 | 2.51 Million AUD | 5.24% |
| 2017 | 2.38 Million AUD | 59.28% |
| 2016 | 1.49 Million AUD | -42.93% |
| 2015 | 2.62 Million AUD | 320.62% |
| 2014 | 624.08 Thousand AUD | 406.11% |
| 2013 | 123.3 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 3.4 Million AUD | -1.74% |
| 2024 Q2 | 2.6 Million AUD | 0.0% |
| 2024 Q4 | 3.4 Million AUD | 0.0% |
| 2023 Q4 | 3.46 Million AUD | 0.0% |
| 2023 Q2 | 2.37 Million AUD | 0.0% |
| 2023 FY | 3.46 Million AUD | 15.72% |
| 2022 Q2 | 2.78 Million AUD | 0.0% |
| 2022 Q4 | 2.99 Million AUD | 0.0% |
| 2022 FY | 2.99 Million AUD | -0.27% |
| 2021 Q2 | 7.47 Million AUD | 0.0% |
| 2021 Q4 | 3 Million AUD | 0.0% |
| 2021 FY | 3 Million AUD | -9.9% |
| 2020 Q4 | 3.33 Million AUD | 0.0% |
| 2020 FY | 3.33 Million AUD | 135.79% |
| 2020 Q2 | 5.49 Million AUD | 0.0% |
| 2019 Q2 | 1.89 Million AUD | 0.0% |
| 2019 Q4 | 1.41 Million AUD | 0.0% |
| 2019 FY | 1.41 Million AUD | -43.69% |
| 2018 FY | 2.51 Million AUD | 5.24% |
| 2018 Q4 | 2.51 Million AUD | 0.0% |
| 2018 Q2 | 1.39 Million AUD | 0.0% |
| 2017 Q4 | 2.38 Million AUD | 0.0% |
| 2017 FY | 2.38 Million AUD | 59.28% |
| 2017 Q2 | 1.66 Million AUD | 0.0% |
| 2016 FY | 1.49 Million AUD | -42.93% |
| 2015 FY | 2.62 Million AUD | 320.62% |
| 2014 FY | 624.08 Thousand AUD | 406.11% |
| 2013 FY | 123.3 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 93.06% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 76.948% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -163.193% |
| Anteris Technologies Ltd | 17.03 Million AUD | 80.006% |
| Control Bionics Limited | 2.75 Million AUD | -23.451% |
| CardieX Limited | 8.56 Million AUD | 60.212% |
| Compumedics Limited | 22.14 Million AUD | 84.618% |
| Cochlear Limited | 904.6 Million AUD | 99.623% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 50.98% |
| Cyclopharm Limited | 13.65 Million AUD | 75.051% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 37.556% |
| Nova Eye Medical Limited | 8.55 Million AUD | 60.164% |
| HeraMED Limited | 1.5 Million AUD | -126.222% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 86.375% |
| ImpediMed Limited | 6.24 Million AUD | 45.431% |
| InhaleRx Limited | 911.41 Thousand AUD | -273.789% |
| LBT Innovations Limited | 5.5 Million AUD | 38.149% |
| Micro-X Limited | 12.63 Million AUD | 73.035% |
| Neurotech International Limited | 314.69 Thousand AUD | -982.545% |
| OncoSil Medical Limited | 1.98 Million AUD | -71.885% |
| PolyNovo Limited | 37.04 Million AUD | 90.803% |
| Respiri Limited | 3.55 Million AUD | 4.142% |
| SomnoMed Limited | 24.78 Million AUD | 86.252% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 67.899% |
| Uscom Limited | 2.07 Million AUD | -64.294% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -23.125% |